Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 82,064 shares at $46.15 ($3.8M) on 2022-12-09, disclosed to the SEC on 2022-12-12.
Seasonal sale ($3.8M) by EVP&Pres, Periph Intervent — this insider has traded BSX in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.15 | 41,032 | $1.9M | 50.0% |
| 2 | $46.15 | 41,032 | $1.9M | 50.0% |
| Total | $46.15 avg | 82,064 | $3.8M | 100% |
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |